IP Library Granted Patent US 9,844,669
Granted Patent B2
US 9,844,669 · App. 12/737,327 · Granted Dec 19, 2017

Cosmetic iontophoresis system

Inventor: Jamal S. Yanaki (Salt Lake City, UT)
Assignee: ActivaDerm, Inc.
A61N1/30A61N1/044A61N1/0448
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,844,669
App. No.
12/737,327
Granted
Dec 19, 2017
Kind
B2
Abstract

Iontophoretically administering a cosmetic agent requires an active electrode and a return electrode secured to the skin ( 150 ). The active electrode includes a flexible biocompatible substrate ( 20, 170 ) having a therapeutic face ( 106, 206 ) configured for disposition toward the skin ( 150 ) and an exterior periphery ( 32, 182 ) shaped to facilitate conformance of the substrate ( 20, 170 ) to the skin ( 150 ) over an intended treatment region. A flexible electrically conductive layer ( 110, 210 ) is disposed on the therapeutic face ( 106, 206 ). The side of the conductive layer ( 110, 210 ) opposite from the substrate ( 20, 170 ) defines a driving face ( 120, 220 ) to which is affixed an electrically conductive adhesive matrix ( 82, 192 ) comprised of a material capable of repeatedly releasably securing the active electrode to the skin ( 150 ) through an applied solution ( 156, 158 ) of the cosmetic agent. A power source ( 76, 186 ) electrically connectable to the return electrode and to the conductive layer ( 110, 210 ) of the active electrode causes migration of the cosmetic agent away from the adhesive matrix ( 82, 192 ) into the skin ( 150 ).

Claims (27)

1. A cosmetic iontophoretic face mask for driving a cosmetic agent into skin of a patient's face located adjacent to the face mask, the cosmetic ionotophoretic face mask comprising:

(a) an active electrode including

a flexible biocompatible substrate having a therapeutic face configured for disposition toward the skin of the patient's face,

an exterior periphery shaped to facilitate conformance of said substrate to said patient's skin over an intended treatment region,

a flexible conductive layer disposed on said therapeutic face,

a driving face located on a distal side of said conductive layer opposite from said substrate and opposite from the patient's skin when said mask is in use,

an electrically conductive adhesive matrix affixed to said driving face, said electrically conductive matrix being capable of repeatedly releasably securing said active electrode to said patient's skin,

a cosmetic agent disposed on said substrate to be driving into said patient's skin by iontophoresis, said cosmetic agent having ionic properties so that it may be migrated into the patient's skin by iontophoresis,

a release liner located on said substrate,

at least one aperture formed through said substrate, said aperture being defined by a continuous interior periphery of said substrate, said interior periphery that defines said aperture being shaped to facilitate the conformance of said therapeutic face of said substrate to the patient's face,

(b) a return electrode for completing an electrical circuit with said active electrode, said patient's skin and said conductive layer of said face mask,

(c) a release liner adjacent said return electrode,

(d) a power source for electrically powering said face mask to iontophoretically deliver said cosmetic agent from said adhesive matrix to said patient's skin by use of

an electromotive force through electrical connection and power of said active electrode, said return electrode and said conductive layer,

(e) an active skin contact surface of active electrode that actually engages and releasable secures a portion of iontophoresis patch at active electrode region of said substrate to the skin of a patient, and

(f) a plurality of adhesive dots on said substrate, said dots being electrically connected to said power source;

wherein powering said circuit with said power supply causes the—administration of said cosmetic agent to said patient's face by transcutaneous delivery through the mechanism of iontophoresis;

wherein said exterior periphery of said substrate is provided with an exterior fitting slit formed through said substrate and extending from the exterior periphery thereof into said substrate to permit portions of said substrate adjacent to and on opposite sides of said exterior fitting slit to be overlapped, thereby enhancing conformity of said mask to the patient's face;

wherein said power supply has an output voltage that ranges from about 1.00 volt to about 15.00 volts;

wherein said electrically conductive layer is sandwiched between said active electrode and said therapeutic face of said substrate; and

wherein said electrically conductive layer is positioned interior of said exterior periphery of said substrate.

2. The device as recited in claim 1 wherein said cosmetic agent has a capability selected from the group comprising (i) the ability to enhance vitality of the patient's skin, (ii) the ability to enhance vitality of the patient's skin, (iii) the ability to effect a cosmetic undertaking on the patient's skin.

3. The device as recited in claim 1 wherein said cosmetic agent reduces skin sensation through use of a numbing compound in order to prepare said skin for an aggressive cosmetic procedure selected from the group consisting of (i) surface abrasion, (ii) hair removal, and (iii) tattoo erasure.

4. The device as recited in claim 1 wherein during said iontophoresis process, direct electrical current is used to cause ions of said cosmetic agent to cross the surface of said patient's skin and to diffuse into underlying tissue without breaking the surface of said skin.

5. The device as recited in claim 1 further comprising contrasting galvanic materials that when coupled by a fluid medium produce minute electrical currents to power said iontophoresis.

6. The device as recited in claim 1 wherein said cosmetic agent is selected from the group consisting of lidocaine, acetic acid, vitamin A, retinyl palmitate, tocopheryl acetate, tocopherol, glucoside, and mandelic acid.

7. The device as recited in claim 1 further comprising a plurality of slits on said substrate and further comprising a release liner which is removable from said mask.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2021
From: ACTIVADERM, INC.
To: YANILUKE PROPERTIES LLC
Reel/Frame 056234/0586 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2017
From: YANAKI, JAMAL
To: ACTIVADERM, INC.
Reel/Frame 044544/0338 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2014
From: ACTIVATEK INC.
To: ACTIVADERM, INC.
Reel/Frame 033704/0889 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2011
From: YANAKI, JAMAL S.
To: ACTIVATEK, INC.
Reel/Frame 025953/0129 →
Continuity (1)
Related Publication 20110160639A1 · Jun 30, 2011